Pfizer Wins Preliminary Injunction Vs. Teva, Ranbaxy In Accupril Suit
Pfizer, Inc. has won a preliminary injunction halting sales of a generic version of the hypertension drug Accupril, marketed by Israeli generics maker Teva Pharmaceuticals and Indian drug maker Ranbaxy Pharmaceuticals....To view the full article, register now.
Already a subscriber? Click here to view full article